Jason D. Graci

1.6k total citations
19 papers, 996 citations indexed

About

Jason D. Graci is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jason D. Graci has authored 19 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jason D. Graci's work include HIV/AIDS drug development and treatment (9 papers), CRISPR and Genetic Engineering (8 papers) and Viral Infections and Immunology Research (7 papers). Jason D. Graci is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), CRISPR and Genetic Engineering (8 papers) and Viral Infections and Immunology Research (7 papers). Jason D. Graci collaborates with scholars based in United States, United Kingdom and Japan. Jason D. Graci's co-authors include Craig E. Cameron, Daniel A. Harki, Blake R. Peterson, Jessica E. Galarraga, Marco Vignuzzi, Christian Castro, Nina F. Gnädig, Victoria Korboukh, D. M. Brown and Ashley Acevedo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Jason D. Graci

19 papers receiving 986 citations

Peers

Jason D. Graci

EPIDE

CCM

GENET

Roberto Mateo United States

Rosario Guinea Spain

Ester Lázaro Spain

Arno L. W. van Vliet Netherlands

Simon P. Tucker United States

Guanghui Yi United States

Tim J. Dalebout Netherlands

Zhuhui Huang United States

Ewan P. Plant United States

Sudip Khadka United States

Roberto Mateo United States

Jason D. Graci

285 ×0.6

340 ×0.9

192 ×0.8

EPIDE

177 ×0.9

CCM

106 ×0.6

GENET

Citations per year, relative to Jason D. Graci Jason D. Graci (= 1×) peers Roberto Mateo

Countries citing papers authored by Jason D. Graci

Since Specialization

Citations

This map shows the geographic impact of Jason D. Graci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason D. Graci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason D. Graci more than expected).

Fields of papers citing papers by Jason D. Graci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason D. Graci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason D. Graci. The network helps show where Jason D. Graci may publish in the future.

Co-authorship network of co-authors of Jason D. Graci

This figure shows the co-authorship network connecting the top 25 collaborators of Jason D. Graci. A scholar is included among the top collaborators of Jason D. Graci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason D. Graci. Jason D. Graci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Branstrom, Arthur, Liangxian Cao, Bansri Furia, et al.. (2022). Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12. 832816–832816. 10 indexed citations

Graci, Jason D., Guangming Chen, Gillian M. Schiralli Lester, et al.. (2017). Identification of benzazole compounds that induce HIV-1 transcription. PLoS ONE. 12(6). e0179100–e0179100. 2 indexed citations

Zhang, Nanjing, Anthony Turpoff, Xiaoyan Zhang, et al.. (2015). Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B. Bioorganic & Medicinal Chemistry Letters. 26(2). 594–601. 10 indexed citations

Chen, Guangming, Hongyu Ren, Nanjing Zhang, et al.. (2015). 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B. Bioorganic & Medicinal Chemistry Letters. 25(4). 781–786. 10 indexed citations

Korboukh, Victoria, Ashley Acevedo, Marco Vignuzzi, et al.. (2014). RNA Virus Population Diversity, an Optimum for Maximal Fitness and Virulence. Journal of Biological Chemistry. 289(43). 29531–29544. 77 indexed citations

Gu, Zhengxian, Jason D. Graci, Frederick Lahser, et al.. (2013). Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy. 57(7). 3250–3261. 15 indexed citations

Graci, Jason D., Nina F. Gnädig, Jessica E. Galarraga, et al.. (2011). Mutational Robustness of an RNA Virus Influences Sensitivity to Lethal Mutagenesis. Journal of Virology. 86(5). 2869–2873. 45 indexed citations

Micheva‐Viteva, Sofiya, Yoshifumi Kobayashi, Leonard C. Edelstein, et al.. (2011). High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor. Journal of Biological Chemistry. 286(24). 21083–21091. 37 indexed citations

Graci, Jason D., Joseph M. Colacino, Stuart W. Peltz, Joseph P. Dougherty, & Zhengxian Gu. (2009). HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs. Antiviral chemistry & chemotherapy. 19(5). 177–187. 5 indexed citations

10.

Graci, Jason D., Eric D. Smidansky, Eric W. Barr, et al.. (2008). Lethal Mutagenesis of Picornaviruses with N-6-Modified Purine Nucleoside Analogues. Antimicrobial Agents and Chemotherapy. 52(3). 971–979. 42 indexed citations

11.

Graci, Jason D. & Craig E. Cameron. (2008). Therapeutically Targeting Rna Viruses Via Lethal Mutagenesis. Future Virology. 3(6). 553–566. 51 indexed citations

12.

Harki, Daniel A., et al.. (2007). Synthesis of a Universal 5‐Nitroindole Ribonucleotide and Incorporation into RNA by a Viral RNA‐Dependent RNA Polymerase. ChemBioChem. 8(12). 1359–1362. 18 indexed citations

13.

Graci, Jason D., Daniel A. Harki, David Franco, et al.. (2007). Lethal Mutagenesis of Poliovirus Mediated by a Mutagenic Pyrimidine Analogue. Journal of Virology. 81(20). 11256–11266. 42 indexed citations

14.

Moriyama, K., Tetsuya Suzuki, Kazuo Negishi, et al.. (2007). Effects of Introduction of Hydrophobic Group on Ribavirin Base on Mutation Induction and Anti-RNA Viral Activity. Journal of Medicinal Chemistry. 51(1). 159–166. 25 indexed citations

15.

Harki, Daniel A., Jason D. Graci, Jessica E. Galarraga, et al.. (2006). Synthesis and Antiviral Activity of 5-Substituted Cytidine Analogues: Identification of a Potent Inhibitor of Viral RNA-Dependent RNA Polymerases. Journal of Medicinal Chemistry. 49(21). 6166–6169. 36 indexed citations

16.

Graci, Jason D. & Craig E. Cameron. (2005). Mechanisms of action of ribavirin against distinct viruses. Reviews in Medical Virology. 16(1). 37–48. 409 indexed citations

17.

Graci, Jason D. & Craig E. Cameron. (2004). Challenges for the Development of Ribonucleoside Analogues as Inducers of Error Catastrophe. Antiviral chemistry & chemotherapy. 15(1). 1–13. 22 indexed citations

18.

Graci, Jason D. & Craig E. Cameron. (2002). Quasispecies, Error Catastrophe, and the Antiviral Activity of Ribavirin. Virology. 298(2). 175–180. 105 indexed citations

19.

Harki, Daniel A., Jason D. Graci, Saikat Ghosh, et al.. (2002). Synthesis and Antiviral Evaluation of a Mutagenic and Non-Hydrogen Bonding Ribonucleoside Analogue: 1-β-d-Ribofuranosyl-3-nitropyrrole. Biochemistry. 41(29). 9026–9033. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact